Post-earnings recap
Reported
Thu, Aug 11, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
ResMed's earnings report showed a positive surprise on EPS, indicating better-than-expected profitability. However, the stock fell by 1.12%, likely due to the absence of revenue details and forward guidance. Investors may be concerned about ongoing supply chain issues and their potential impact on future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.49 | N/A | +0.47% |
| Revenue | N/A | N/A | N/A |
Management expressed a cautious optimism regarding future demand. They acknowledged supply chain challenges but emphasized their commitment to innovation.
Management highlighted ongoing demand for their products.
They noted challenges in the supply chain but are working to mitigate them.
The focus remains on innovation and expanding market reach.